Chinese patients with breast cancer exhibit a more invasive ductal carcinoma with larger tumor sizes and higher human epidermal growth factor receptor 2 (Her-2) overexpression than patients from the West (4). This evidence concerns the gene ERBB2 and breast carcinoma.